2003
24 November 2003:
Ernst & Young Entrepreneur of the Year
25 June 2003:
Zealand Pharma and Aventis Sign Licensing Deal
1 May 2003:
Zealand Pharma and Wyeth Enter Collaboration for Cardiovascular Therapy
27 March 2003:
Zealand Pharma and Elan Terminate Betacure Joint Venture. Zealand Pharma raises €5 million from existing investors
Home Legal Disclaimer Updated: 31.1.2012